Tomorrowlabs founders Dr. Dominik Thor and Dr. Dominik Duscher shares a common fascination for the use of scientific findings from medical and pharmaceutical research in cosmetics. With Tomorrowlabs, the two researchers have founded a bio-tech company that is dedicated to the optimal effect of its products through a strict focus on scientifically proven technologies. Tomorrowlabs and its products stand for visible effects instead of empty promises and the manufacture of sustainable products in Austria and Germany according to Clean Beauty principles (without questionable ingredients that are harmful to the environment or health) and according to Longevity guidelines. dr Dominik Duscher studied medicine in Vienna before working for several years at Stanford University in California as a researcher in the fields of regenerative medicine, stem cell research and biomaterial sciences after studying at leading European universities in the USA. As a specialist in plastic surgery, he has studied the skin as our largest organ in terms of dysfunction and how skin problems such as wound healing disorders can be treated by influencing the communication between our cells. Research into the natural regeneration of our cells and the use of this knowledge in the context of new therapies plays an important role in medical research. Dr Dominik Thor studied pharmaceutical sciences in the USA with a specialization in pharmaceutical chemistry. As that part of pharmaceutical research that is considered the science of medicinal substances and medicinal products, pharmaceutical chemistry deals with the production of new active ingredients and medicinal products, but also with the use of new active ingredients in cosmetics (e.g. creams and serums) and the distinction between medicine and cosmetics. The pharmacist Thor and the plastic surgeon Duscher met after completing their studies in Austria and researched together how the optimal functionality of cellular signaling pathways, which control the regeneration of the skin and our hair, can be guaranteed. Her thesis is that only perfectly functioning cells can ensure the basis of beautiful, healthy and youthful-looking skin and full hair. However, if there is a loss of function of these smallest building blocks of our body, then visible quality losses are the result. The decisive factor here is the knowledge that the most important regeneration mechanisms in the cell are controlled via a signaling pathway. This discovery eventually led to the HIF signaling pathway receiving the 2019 Nobel Prize in Medicine. But Dr. Dominik Duscher and Dr. As early as 2015, Dominik Thor were looking for solutions on how this regeneration mechanism can be restored to a youthful state, even if the cell is older. The result of this research is the HSF technology and the creation of Tomorrowlabs as a biotechnology company dedicated to the development of particularly effective cosmetic products for skin and hair. Tomorrowlabs products based on the research of Duscher and Thor address signs of aging (anti-aging products), skin problems and sensitive, particularly sensitive skin as well as hereditary hair loss. Instead of the sole focus on active ingredients that are otherwise frequently used, which strictly speaking only have an auxiliary function in the regenerative work of the body, such as hyaluronic acid (retinol), vitamins C, A, E, collagen, Q10 and many others, HSF from Tomorrowlabs focuses on the Activation of the body's own regeneration. Together with leading universities in Germany, Austria and the USA and leading research institutes and the involvement of various teams of recognized researchers and doctors, Dr. Dominik Thor and Dr. As the founder and managing director of Tomorrowlabs, Dominik Duscher has conducted numerous in-vitro and clinical studies as part of the research and development of HSF products. The aim of the scientists was to optimize the scientific effectiveness of the Tomorrowlabs products, to document them objectively through leading researchers and also to communicate them. The studies have been published in scientific journals and won awards at medical congresses. As leading researchers in the field of longevity - a branch of regenerative medicine that deals with the extension of healthy life spans through prevention, lifestyle changes and therapies - Dr. Dominik Thor and Dr. Dominik Duscher as authors, lecturers and opinion leaders for the communication of the findings of scientific, medical, pharmaceutical and cosmetic research. As a doctor, Dr. Dominik Duscher in Munich Germany's first longevity center.